Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE:VJET), today announced the first published comparative study evaluating its LockeT suture retention device against a traditional internal vascular closure device (VCD) following large bore venous access.

The 172-patient peer-reviewed study, titled "Vascular closure with a suture retention device versus suture-mediated closure system after large bore venous access for electrophysiologic procedures," was published in The Journal of Interventional Cardiology (JICE), a premier publication dedicated to original electrophysiology research and advanced ablation techniques.

The clinical data demonstrated the superior safety and efficacy of the LockeT device compared to Perclose, a leading internal VCD, manufactured and sold by Abbott. Key findings from the study include:

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.